Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Hyperglycemia associated with the use of atypical antipsychotics.

Lindenmayer JP, Nathan AM, Smith RC.

J Clin Psychiatry. 2001;62 Suppl 23:30-8. Review.

2.

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.

Am J Psychiatry. 2003 Feb;160(2):290-6.

PMID:
12562575
3.

Glucose intolerance with atypical antipsychotics.

Hedenmalm K, Hägg S, Ståhl M, Mortimer O, Spigset O.

Drug Saf. 2002;25(15):1107-16.

PMID:
12452735
4.

Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.

Sernyak MJ, Gulanski B, Rosenheck R.

J Clin Psychiatry. 2005 Nov;66(11):1463-7.

PMID:
16420085
5.

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.

Sernyak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck R.

Am J Psychiatry. 2002 Apr;159(4):561-6.

PMID:
11925293
6.

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B.

J Clin Psychiatry. 2003 May;64(5):598-604.

PMID:
12755665
7.

Hyperglycemia and hypertriglyceridemia in real world patients on antipsychotic therapy.

Gupta S, Steinmeyer C, Frank B, Madhusoodanan S, Lockwood K, Lentz B, Keller P.

Am J Ther. 2003 Sep-Oct;10(5):348-55.

PMID:
12975719
8.

Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.

Gianfrancesco FD, Grogg AL, Mahmoud RA, Wang RH, Nasrallah HA.

J Clin Psychiatry. 2002 Oct;63(10):920-30.

PMID:
12416602
9.

Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.

Simpson MM, Goetz RR, Devlin MJ, Goetz SA, Walsh BT.

J Clin Psychiatry. 2001 Sep;62(9):694-700.

PMID:
11681765
10.

Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.

Lambert BL, Chou CH, Chang KY, Tafesse E, Carson W.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):417-25.

PMID:
15786516
11.

[Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].

Rubio G, Gómez-de-la-Cámara A, Ledesma F, Burón JA, Rodríguez-Morales A, Martínez-Junquera G; Grupo Español para el Estudio de la Diabetes en Pacientes Esquizofrénicos.

Med Clin (Barc). 2006 Apr 1;126(12):441-4. Spanish.

PMID:
16620729
12.

Atypical antipsychotics and hyperglycaemia.

Mir S, Taylor D.

Int Clin Psychopharmacol. 2001 Mar;16(2):63-73. Review.

PMID:
11236071
13.

Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.

Cohen D.

Pharmacopsychiatry. 2004 Jan;37(1):1-11. Review.

PMID:
14750042
14.

Hyperglycemia and antipsychotic medications.

Haupt DW, Newcomer JW.

J Clin Psychiatry. 2001;62 Suppl 27:15-26; discussion 40-1. Review.

15.

Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.

Feldman PD, Hay LK, Deberdt W, Kennedy JS, Hutchins DS, Hay DP, Hardy TA, Hoffmann VP, Hornbuckle K, Breier A.

J Am Med Dir Assoc. 2004 Jan-Feb;5(1):38-46.

PMID:
14706127
16.

Elevation of prolactin levels by atypical antipsychotics.

Turrone P, Kapur S, Seeman MV, Flint AJ.

Am J Psychiatry. 2002 Jan;159(1):133-5.

PMID:
11772702
17.

Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.

Am J Psychiatry. 2002 Feb;159(2):255-62. Erratum in: Am J Psychiatry 2002 Dec;159(12):2132.

PMID:
11823268
18.

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC.

Arch Gen Psychiatry. 2005 Jan;62(1):19-28.

PMID:
15630069
19.
20.

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.

Leslie DL, Rosenheck RA.

Am J Psychiatry. 2004 Sep;161(9):1709-11.

PMID:
15337666

Supplemental Content

Support Center